Abstract
Optimal T cell function lies at the heart of an efficient adaptive response. T cell activation is a highly regulated process and it is important to ensure that activation occurs in the proper context to prevent the development of harmful conditions such as autoimmunity and excessive inflammatory responses. One of the important factors in this process is the strength of the primary activating signal which is delivered upon ligation of the T cell receptor (TCR) with the major histocompatibility complex (MHC) encoded class I or class II molecules bearing the antigenic peptide. The strength of signal (SOS), in turn, depends on several factors: the affinity/avidity of the TCR for the MHC–peptide complex, the time of engagement, antigen concentrations, costimulatory interactions, etc. This chapter reviews the effects of SOS on thymocyte selection and education, T cell costimulation, proliferation, survival, formation of T helper T H 1 and T H 2 subsets, responses to infectious agents etc. The role of the SOS in modulating diverse T cell responses is well appreciated. However, further studies are required to understand the mechanisms by which SOS signals are relayed from the TCR to downstream effectors to modulate T cell activation and responses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zinkernagel R, Doherty P (1974) Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis. Nature 251:547–548
Goldsby RA, Kindt TJ, Osborne BA (2000) Kuby immunology. WH Freeman, New York
Paul WE (Ed) (2008) Fundamental immunology. Lippincott Williams and Wilkins, Philadelphia
Iwashima M (2003) Kinetic perspectives of T cell antigen receptor signaling. Immunol Rev 191:196–210
Lin J, Weiss A (2001) T cell receptor signalling. J Cell Sci 114:243
Lewis R (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19:497–521
Krummel M (2007) Immunological synapses: breaking up may be good to do. Cell 129: 653–655
Bretscher P, Cohn M (1970) A theory of self-nonself discrimination. Science 169:1042–1049
Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP (1992) CD28 mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607
Gross J, St John T, Allison J (1990) The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J Immunol 144:3201
Riley J, Mao M, Kobayashi S, Biery M, Burchard J, Cavet G, Gregson B, June C, Linsley P (2002) Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci USA 99:11790
Martin M, Schneider H, Azouz A, Rudd C (2001) Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 194:1675
Jacobelli J, Andres P, Boisvert J, Krummel M (2004) New views of the immunological synapse: variations in assembly and function. Curr Opin Immunol 16:345–352
Brunner-Weinzerl MC, Hoff H, Burmester GR (2004) Multiple functions for CD28 and CTLA4 during different phases of T cell responses: implications for arthritis and autoimmune disease. Arthritis Res Ther 6:45
Lucas P, Negishi I, Nakayama K, Fields L, Loh D (1995) Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol 154:5757
Carreno B, Collins M (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20:29–53
Pagès F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J, Olive D (1994) Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369: 327–329
Yang W, Olive D (1999) Tec kinase is involved in transcriptional regulation of IL-2 and IL-4 in the CD28 pathway. Eur J Immunol 29:1842–1849
Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O (2001) CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15:935–945
Tivol E, Borriello F, Schweitzer A, Lynch W, Bluestone J, Sharpe A (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541
Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee K, Thompson C, Griesser H, Mak T (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985
Chen Z, Stockton J, Mathis D, Benoist C (2006) Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc Natl Acad Sci USA 103:16400
Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Rnningen KS, Guja C, Ionescu-Trgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511
Chambers C, Kuhns M, Egen J, Allison J (2001) CTLA-4-mediated inhibition in regulation of T-cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19:565–594
Rudd C, Schneider H (2003) Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 3:544–556
Teft W, Kirchhof M, Madrenas J (2006) A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65–97
Rudd C (2008) The reverse stop-signal model for CTLA4 function. Nat Rev Immunol 8:153–160
Elgueta R, Benson M, de Vries V, Wasiuk A, Guo Y, Noelle R (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229:152–172
Van Kooten C, Banchereau J (1997) Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330
Campbell K, Ovendale P, Kennedy M, Fanslow W, Reed S, Maliszewski C (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283–290
Lei X, Ohkawara Y, Stämpfli M, Mastruzzo C, Marr R, Snider D, Xing Z, Jordana M (1998) Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest 101:1342
Dong C, Temann U, Flavell R (2001) Cutting edge: critical role of inducible costimulator in germinal center reactions. J Immunol 166:3659
Iiyama R, Kanai T, Uraushihara K, Totsuka T, Nakamura T, Miyata T, Yagita H, Kushi A, Suzuki K, Tezuka K, Watanabe M (2003) The role of inducible co-stimulator (ICOS)/B7-related protein-1 (B7RP-1) interaction in the functional development of Peyer’s patches. Immunol Lett 88:63–70
Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B, Odermatt B, Bachmann M (1999) OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11:699
Sharpe A (2009) Mechanisms of costimulation. Immunol Rev 229:5
Dawicki W, Bertram E, Sharpe A, Watts T (2004) 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J Immunol 173:5944
Nolte M, van Olffen R, Van Gisbergen K, van Lier R (2009) Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 229:216–231
Wang N, Satoskar A, Faubion W, Howie D, Okamoto S, Feske S, Gullo C, Clarke K, Sosa M, Sharpe A, Terhorst C (2004) The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med 199:1255
Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10:1563
Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM (2003) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4:670–679
Rodriguez-Manzanet R, DeKruyff R, Kuchroo V, Umetsu D (2009) The costimulatory role of TIM molecules. Immunol Rev 229:259–270
Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536–541
McIntire J, Umetsu D, DeKruyff R (2004) TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol 25:335–348
Rachmilewitz J, Lanzavecchia A (2002) A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol 23:592–595
Wulfing C, Rabinowitz J, Beeson C, Sjaastad M, McConnell H, Davis M (1997) Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med 185:1815
Ahmed A, Mukherjee S, Nandi D (2009) Intracellular concentrations of Ca2 + modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4 + T lymphocytes. Immunology 126:363
Kirchgessner H, Dietrich J, Scherer J, Isomaki P, Korinek V, Hilgert I, Bruyns E, Leo A, Cope A, Schraven B (2001) The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCRζ chain. J Exp Med 193:1269
Schade A, Levine A (2004) Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength. J Immunol 172:5828
Murphy L, Smith S, Chen R, Fingar D, Blenis J (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556–564
Guo Z, Clydesdale G, Cheng J, Kim K, Gan L, McConkey D, Ullrich S, Zhuang Y, Su B (2002) Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction. Mol Cell Biol 22:5761
Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, Luban J (2004) Cyclophilin A regulates TCR signal strength in CD4 + T cells via a proline-directed conformational switch in Itk. Immunity 21:189–201
Tarakhovsky A, Kanner S, Hombach J, Ledbetter J, Muller W, Killeen N, Rajewsky K (1995) A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535
Azzam H, Grinberg A, Lui K, Shen H, Shores E, Love P (1998) CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 188:2301–2311
Park JH, Adoro S, Lucas PJ, Sarafova SD, Alag AS, Doan LL, Erman B, Liu X, Ellmeier W, Bosselut R, Feigenbaum L, Singer A (2007) ‘Coreceptor tuning’: cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol 8(10):1049–1059
Hollander G, Gill J, Zuklys S, Iwanami N, Liu C, Takahama Y (2006) Cellular and molecular events during early thymus development. Immunol Rev 209:28–46
Casetti R, Martino A (2008) The plasticity of γδ T cells: innate immunity, antigen presentation and new immunotherapy. Cell Mol Immunol 5:161
Mathis D, Benoist C (2009) Aire. Annu Rev Immunol 27:287–312
Pennington D, Silva-Santos B, Hayday A (2005) γδT cell development having the strength to get there. Curr Opin Immunol 17:108–115
Hayes S, Love P (2006) Strength of signal: a fundamental mechanism for cell fate specification. Immunol Rev 209:170–175
Lauritsen J, Haks M, Lefebvre J, Kappes D, Wiest D (2006) Recent insights into the signals that control αβ/γδ-lineage fate. Immunol Rev 209:176–190
Hayes S, Li L, Love P (2005) TCR signal strength influences αβ/γδ lineage fate. Immunity 22:583–593
Haks M, Lefebvre J, Lauritsen J, Carleton M, Rhodes M, Miyazaki T, Kappes D, Wiest D (2005) Attenuation of γδTCR signaling efficiently diverts thymocytes to the αβ lineage. Immunity 22:595–606
Fehling H, Gilfillan S, Ceredig R (1999) αβ/γδ lineage commitment in the thymus of normal and genetically manipulated mice. Adv Immunol 71:1–76
Hayes S, Shores E, Love P (2003) An architectural perspective on signaling by the pre-, αβ and γδ T cell receptors. Immunol Rev 191:28–37
Hayes S, Love P (2002) Distinct structure and signaling potential of the γδTCR complex. Immunity 16:827–838
Garbe A, von Boehmer H (2007) TCR and Notch synergize in αβ versus γδ lineage choice. Trends Immunol 28:124–131
Hogquist K, Baldwin T, Jameson S (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5:772–782
Love P, Lee J, Shores E (2000) Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection. J Immunol 165:3080
van Oers N, Tohlen B, Malissen B, Moomaw C, Afendis S, Slaughter C (2000) The 21-and 23-kD forms of TCRζ are generated by specific ITAM phosphorylations. Nat Immunol 1:322–328
Werlen G, Hausmann B, Palmer E (1999) A motif in the T-cell receptor controls positive selection by modulating ERK activity. J Immunol 29:1912–1918
Mariathasan S, Zakarian A, Bouchard D, Michie A, Zuniga-Pflucker J, Ohashi P (2001) Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J Immunol 167:4966
McNeil L, Starr T, Hogquist K (2005) A requirement for sustained ERK signaling during thymocyte positive selection in vivo. Proc Natl Acad Sci USA 102:13574
Dower N, Stang S, Bottorff D, Ebinu J, Dickie P, Ostergaard H, Stone J (2000) RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 1:317
Fischer A, Katayama C, Pagès G, Pouysségur J, Hedrick S (2005) The role of ERK1 and ERK2 in multiple stages of T cell development. Immunity 23:431–443
He X, Kappes D (2006) CD4/CD8 lineage commitment: light at the end of the tunnel? Curr Opin Immunol 18:135–142
Wiest D, Yuan L, Jefferson J, Benveniste P, Tsokos M, Klausner R, Glimcher L, Samelson L, Singer A (1993) Regulation of T cell receptor expression in immature CD4 + CD8 + thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J Exp Med 178:1701
Hernández-Hoyos G, Sohn S, Rothenberg E, Alberola-Ila J (2000) Lck activity controls CD4/CD8 T cell lineage commitment. Immunity 12:313–322
Yasutomo K, Doyle C, Miele L, Germain R (2000) The duration of antigen receptor signalling determines CD4 + versus CD8 + T-cell lineage fate. Nature 404:506–510
Brugnera E, Bhandoola A, Cibotti R, Yu Q, Guinter T, Yamashita Y, Sharrow S, Singer A (2000) Coreceptor reversal in the thymus: signaled CD4 + CD8 + thymocytes initially terminate CD8 transcription even when differentiating into CD8 + T cells. Immunity 13:59
Sarafova S, Erman B, Yu Q, Van Laethem F, Guinter T, Sharrow S, Feigenbaum L, Wildt K, Ellmeier W, Singer A (2005) Modulation of coreceptor transcription during positive selection dictates lineage fate independently of TCR/coreceptor specificity. Immunity 23:75–87
Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348
Mowen K, Glimcher L (2004) Signaling pathways in Th2 development. Immunol Rev 202:203–222
Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M, Weiner H, Kuchroo V (2006) Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441:235–238
Chen Z, O’Shea J (2008) Th17 cells: a new fate for differentiating helper T cells. Immunol Res 41:87–102
Bettelli E, Korn T, Kuchroo VK (2007) Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19:652–657
Zhu J, Paul W (2008) CD4 T cells: fates, functions, and faults. Blood 112:1557
Secrist H, DeKruyff R, Umetsu D (1995) Interleukin 4 production by CD4 + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 181:1081
Iezzi G, Scotet E, Scheidegger D, Lanzavecchia A (1999) The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur J Immunol 29:4092–4101
Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K (1995) Extent of T cell receptor ligation can determine the functional differentiation of naive CD4 + T cells. J Exp Med 182:1591
Hosken N, Shibuya K, Heath A, Murphy K, O’garra A (1995) The effect of antigen dose on CD4 + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 182:1579
Tao X, Constant S, Jorritsma P, Bottomly K (1997) Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4 + T cell differentiation. J Immunol 159:5956
Sloan-Lancaster J, Allen P (1996) Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 14:1–27
Alberola-Ila J, Takaki S, Kerner J, Perlmutter R (1997) Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 15:125–154
Boutin Y, Leitenberg D, Tao X, Bottomly K (1997) Distinct biochemical signals characterize agonist-and altered peptide ligand-induced differentiation of naive CD4 + T cells into Th1 and Th2 subsets. J Immunol 159:5802
Leitenberg D, Bottomly K (1999) Regulation of naïve T cell differentiation by varying the potency of tcr signal transduction. Semin Immunol 11:283–292
Badou A, Savignac M, Moreau M, Leclerc C, Foucras G, Cassar G, Paulet P, Lagrange D, Druet P, Guery J, Pelletier L (2001) Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-gamma production. Eur J Immunol 31:2487–2496
Dumont F, Staruch M, Fischer P, DaSilva C, Camacho R (1998) Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 160:2579
Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, Su M, Penix L, Davis R, Flavell R (1998) Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 17:2817
Dong C, Yang D, Wysk M, Whitmarsh A, Davis R, Flavell R (1998) Defective T cell differentiation in the absence of Jnk1. Science 282:2092
Yang D, Conze D, Whitmarsh A, Barrett T, Davis R, Rincon M, Flavell R (1998) Differentiation of CD4 T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575–585
Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, Ackerman K, Haley K, Galle PR, Szabo SJ, Drazen JM, De Sanctis GT, Glimcher LH (2002) Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336
Szabo S, Kim S, Costa G, Zhang X, Fathman C, Glimcher L (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–669
Zhu J, Min B, Hu-Li J, Watson C, Grinberg A, Wang Q, Killeen N, Urban J, Guo L, Paul W (2004) Conditional deletion of Gata3 shows its essential function in Th1-Th2 responses. Nat Immunol 5:1157–1165
Brogdon J, Leitenberg D, Bottomly K (2002) The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4 + T cells. J Immunol 168:3825
Salomon B, Bluestone J (1998) Cutting edge: LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J Immunol 161:5138
Wülfing C, Sjaastad M, Davis M (1998) Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci USA 95:6302
Sakaguchi S (2000) Regulatory T cells key controllers of immunologic self-tolerance. Cell 101:455–458
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151
Su L, Creusot R, Gallo E, Chan S, Utz P, Fathman C, Ermann J (2004) Murine CD4 + CD25 + regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. J Immunol 173:4994
Horwitz D, Zheng S, Gray J (2008) Natural and TGF-β–induced Foxp3 + CD4 + CD25 + regulatory T cells are not mirror images of each other. Trends Immunol 29:429–435
Jordan M, Boesteanu A, Reed A, Petrone A, Holenbeck A, Lerman M, Naji A, Caton A (2001) Thymic selection of cd4 + cd25 + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301–306
Salomon B, Lenschow D, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone J (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4 + CD25 + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440
Tai X, Cowan M, Feigenbaum L, Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6:152–162
Yu P, Haymaker CL, Divekar RD, Ellis JS, Hardaway J, Jain R, Tartar DM, Hoeman CM, Cascio JA, Ostermeier A, Zaghouani H (2008) Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol 181:73
Liang S, Alard P, Zhao Y, Parnell S, Clark S, Kosiewicz M (2005) Conversion of CD4 + CD25-cells into CD4 + CD25 + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201:127
Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig M, von Boehmer H (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219–1227
Zheng S, Wang J, Stohl W, Kim K, Gray J, Horwitz D (2006) TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4 + CD25 + regulatory cells. J Immunol 176:3321
Malek T (2008) The biology of interleukin-2. Annu Rev Immunol 26:453–479
Fontenot J, Rasmussen J, Gavin M, Rudensky A (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142–1151
Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, Noelle R, Horak I (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4 + T cells. Eur J Immunol 25:3053–3059
Beissert S, Schwarz A, Schwarz T (2006) Regulatory T cells. J Invest Dermatol 126:15–24
Hombach A, Kofler D, Hombach A, Rappl G, Abken H (2007) Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2. J Immunol 179:7924
Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka K, Lin C, Hanke T, Hunig T, Kerkau T, Gold R (2005) Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 202:445
Baecher-Allan C, Viglietta V, Hafler D (2002) Inhibition of human CD4 + CD25 + high regulatory T cell function. J Immunol 169:6210
Baecher-Allan C, Hafler D (2006) Human regulatory T cells and their role in autoimmune disease. Immunol Rev 212:203–216
Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science 299:1033
Kalia V, Sarkar S, Gourley T, Rouse B, Ahmed R (2006) Differentiation of memory B and T cells. Curr Opin Immunol 18:255–264
Williams M, Bevan M (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25:171–192
Jacob J, Baltimore D (1999) Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593–597
Curtsinger J, Johnson C, Mescher M (2003) CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171:5165
Badovinac V, Porter B, Harty J (2004) CD8 + T cell contraction is controlled by early inflammation. Nat Immunol 5:809–817
Day C, Kaufmann D, Kiepiela P, Brown J, Moodley E, Reddy S, Mackey E, Miller J, Leslie A, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfel M, Wherry EJ, Coovadia HM, Goulder PJR, Klenerman P, Ahmed R, Freeman GJ, Walker BD (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350–354
Lim D, Höllsberg P, Hafler D (2002) Strength of prior stimuli determines the magnitude of secondary responsiveness in CD8 + T cells. Cell Immunol 217:36–46
Wherry E, Ha S, Kaech S, Haining W, Sarkar S, Kalia V, Subramaniam S, Blattman J, Barber D, Ahmed R (2007) Molecular signature of CD8 + T cell exhaustion during chronic viral infection. Immunity 27:670–684
Barber D, Wherry E, Masopust D, Zhu B, Allison J, Sharpe A, Freeman G, Ahmed R (2005) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687
Li J, Huston G, Swain S (2003) IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198:807
Kaech S, Tan J, Wherry E, Konieczny B, Surh C, Ahmed R (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4:1191–1198
Lozza L, Rivino L, Guarda G, Jarrossay D, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A, Geginat J (2008) The strength of T cell stimulation determines IL-7 responsiveness, secondary expansion, and lineage commitment of primed human CD4 + IL-7Rhi T cells. Eur J Immunol 38:30
Williams M, Ravkov E, Bevan M (2008) Rapid culling of the CD4 + T cell repertoire in the transition from effector to memory. Immunity 28:533–545
Murtaza A, Kuchroo V, Freeman G (1999) Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int Immunol 11:407
Bonnevier J, Mueller D (2002) Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J Immunol 169:6659
Wu Y, Guo Y, Huang A, Zheng P, Liu Y (1997) CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med 185:1327
Madrenas J, Chau L, Teft W, Wu P, Jussif J, Kasaian M, Carreno B, Ling V (2004) Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand. J Immunol 172:5948
Hueber A, Matzkies F, Rahmeh M, Manger B, Kalden J, Nagel T (2006) CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas. Immunol Cell Biol 84:51–58
Mukherjee S, Ahmed A, Malu S, Nandi D (2006) Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4 + T cells depends on strength of the CD3 signal: critical role for IL-2. J Leukoc Biol 80:66
Mukherjee S, Ahmed A, Nandi D (2005) CTLA4-CD80/CD86 interactions on primary mouse CD4 + T cells integrate signal-strength information to modulate activation with Concanavalin A. J Leukoc Biol 78:144
Anderson D, Bieganowska K, Bar-Or A, Oliveira E, Carreno B, Collins M, Hafler D (2000) Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat Med 6:211–214
Kuhns M, Epshteyn V, Sobel R, Allison J (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4 + T cells. Proc Natl Acad Sci USA 97:12711
Egen J, Kuhns M, Allison J (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3:611–618
Hildeman D, Zhu Y, Mitchell T, Kappler J, Marrack P (2002) Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 14:354–359
Krammer P, Arnold R, Lavrik I (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532–542
Lenardo M (1991) Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858–861
Arnold R, Brenner D, Becker M, Frey C, Krammer P (2006) How T lymphocytes switch between life and death. Eur J Immunol 36:1654–1658
Gett A, Sallusto F, Lanzavecchia A, Geginat J (2003) T cell fitness determined by signal strength. Nat Immunol 4:355–360
Alexander-Miller M, Leggatt G, Sarin A, Berzofsky J (1996) Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med 184:485–492
Critchfield J, Racke M, Zuniga-Pflucker J, Cannella B, Raine C, Goverman J, Lenardo M (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139
Lenardo M, Chan F, Hornung F, McFarland H, Siegel R, Wang J, Zheng L (1999) Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment 1. Annu Rev Immunol 17:221–253
Acknowledgements
The suggestions and comments by members of the DpN laboratory and colleagues from different institutions during our studies on T cell activation are greatly appreciated. We thank the Department of Biotechnology, Government of India and the Commission of the European Communities for financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ahmed, A., Nandi, D. (2011). T Cell Activation and Function: Role of Signal Strength. In: Molina-París, C., Lythe, G. (eds) Mathematical Models and Immune Cell Biology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7725-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7725-0_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7724-3
Online ISBN: 978-1-4419-7725-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)